Measles virus (MV) encodes the fusion protein (F) that mediates cell fusion and intercellular spread of the virus, and is homologous to the carboxy terminus of the neuropeptide substance P (SP). In addition, the oligopeptide Z-D-Phe-L-Phe-Gly, also homologous to F and SP, inhibits MV fusion with target cells. These observations raise the question of whether MV uses the SP receptor (SPR) during a specific phase of its infectious cycle. In this report, we examine the structural and functional consequences of this interaction and show, using cross-linking studies, that MV and SP specifically bind to a 52-58-kD protein, previously reported to comprise the SPR on human IM-9 lymphoblasts. Moreover, bound MV and SP are shown to reciprocally displace each other from these cells. In addition, we demonstrate that anti-SP antisera inhibits the cell-to-cell spread of MV, and that SP blocks MV fusion with target cells. These results indicate the presence of MV-SPR interactions during viral fusion, and suggest possible novel mechanisms for viral entry into cells. 
Introduction
The molecular mechanisms by which viruses bind to and infect specific tissues/cells to cause disease have yet to be fully characterized. Based on a number of recent studies, viruses may have evolved to use specific cell surface receptors that are important for endogenous cell-cell recognition mechanisms or for nonviral ligands. For example, it has been reported that rabies (1), vaccinia (2), Epstein-Barr (3), HIV-1 (4) , and reovirus type 3 (5) bind to the acetylcholine receptor, epidermal growth factor receptor, complement receptor, T cell antigen, and adrenergic receptor, respectively. However, it is still unclear how viruses use these receptors during the various stages of viral attachment, fusion, replication, and spread into noninfected cells.
The envelope of measles virus (MV)' contains two glycoproteins. The large hemagglutinin (HA) with a molecular weight of -80 kD, is responsible for initial virus attachment and hemagglutination of red blood cells (6) , whereas the smaller fusion protein (F) is involved in cell fusion and intercellular spread of the virus (7) . The fusion activity of F is generated by cleavage into a nonglycosylated Fl peptide (Fl) with a molecular weight of 41 kD, and a glycosylated F2 peptide with a molecular weight of 18-20 kD. The amino terminus of Fl of MV is essential for its functional activity, as demonstrated by the fact that synthetic oligopeptides of similar structure to the NH2-terminus ofFl inhibit MV replication and cell-to-cell fusion (8) . Interestingly, the NH2-terminus of Fl, -Phe-Ala-Gly-is homologous to that of the carboxy terminus of the neuropeptide substance P (SP), -Phe-Phe-Gly-. Moreover, the oligopeptide Z-D-Phe-L-Phe-Gly has been shown to inhibit MV fusion (9) , and SP has been reported to reduce the amount of MV production (10) . These data suggest that MV might use the SP receptor (SPR) during viral infection.
Here, we report the structural and functional consequences of the interaction between MV and SPR, and suggest possible novel mechanisms for MV entry into cells.
Methods
RIA. Guinea pig anti-MV polyclonal antibody (GPaMV) (NIH Research reference reagent) or normal guinea pig serum (Cappel Laboratories, Cochranville, PA) were diluted 1:10,000-1:30,000 with PBS and incubated in 96-well plates at 40C overnight. Wells were then blocked with PBS containing 1% BSA-PBS at 40C for 1 h. 1.0 OD260 U of MV were then added into each well and incubated at 4°C for 1 h. After the excess MV was removed, various concentrations of normal rabbit serum (NRS) (Cappel Laboratories) or rabbit anti-SP polyclonal antibodies (RabaSP) were incubated at 4°C for I h, and then 10,000 cpm of '251-protein A was incubated at 40C for an additional 1 h. After washing with BSA-PBS containing 0.5% Tween-20, the 'y-radioactivity of individual wells was determined in a ?y-counter.
Immunoprecipitation 
Results and Discussion
Initial experiments were carried out to investigate the structural similarities between MV and SP: We examined if RabaSP antibodies recognize epitopes on MV using a modified sandwich RIA. As shown in Fig. 1 , RabaSP recognizes MV at concentrations as low as 1:600, whereas NRS failed to bind to MV even at.a 1:30. The possibility that MV and SP bind to the same proteins was examined by immunoprecipitating peptide and virus cross-linked to IM-9 cells with the above antibodies. Human IM-9 cells, known to express the SPR (12), were biosynthetically labeled with [135S]met as previously described (1 1), and cell surface proteins were specifically cross-linked to either SP or MV using a thiol cleavable cross-linking agent DSP. As shown in Fig. 2 , RabaSP (lanes 4 and 5) specifically precipitated a protein with the apparent molecular weight of 52-58 kD in both MV-(lane 5) and SPcross-linked (lane 4) cells compared with control serum (lanes 2 and 3). Our previous studies using specific [ (Fig. 3 A) . The binindg ofMV to IM-9 cells, detected by a GPaMV and a secondary FITC-labeled GaGP, was also reversibly displaced with unlabeled SP (Fig. 3 B) .
The hypothesis that MV may use the SPR during the attachment and fusion process was explored further in functional studies by examining the activity of RabaSP on MV plaque formation, and the effect of SP on MV fusion. Table I shows the effect of GPaMV and RabaSP on MV plaque formation. The persistence of MV inhibition at day 6 compared with day 4 implies neutralization of MV by GPaMV. In contrast, the lack ofinhibition at day 6 compared with day 4 in the RabaSP-treated plates suggests that the delay in the MV cytopathic effect caused by RabaSP is due principally to its inhibition of viral induced cell-to-cell fusion (18) . It has been shown that MV-infected cells express viral HA and F on the cell surface, which are replaced every 9-10 h (19), and because antibodies are capable of capping with these cell surface viral antigens (20) , the concentration ofantibodies in this assay may decrease during incubation if cells are infected with MV. Therefore, our data suggest that GPaMV inhibits MV infection, whereas RabaSP fails to completely inhibit MV infection, but nevertheless significantly inhibits the spread of the MV most likely by inhibiting viral induced cell-cell fusion processes (18) .
The effect of SP on viral fusion was analyzed further using the fluorescent dye R18 (15) . This assay is based on the evidence that release of fluorescent self-quenching of dye from viral-membrane to cell-membrane reflects the virus-cell fusion process. Fig. 4 shows the fusion kinetics of R18-loaded MV with Vero cells which were pretreated with or without Z-DPhe-L-Phe-Gly or SP. The loaded R18 within MV diffused into Vero cell membranes rapidly after warming up at 370C, and fluorescence intensity was increased, demonstrating MV fusion with Vero cells (Fig. 4 A) . In contrast, the slope of R18 fluorescence in SP (Fig. 4 B) and the oligopeptide- (Fig. 4 C (15) (Fig. 4 D) . However, both SP (Fig. 4 E) and the oligo-peptide (Fig. 4 F) cell surface proteins that had been previously identified as receptors for such diverse ligands as neurotransmitters and growth factors (1) (2) (3) (4) (5) . One mechanism which may explain this evolutionary adaptation is that viral components that are essential for the binding/attachment/fusion process may exhibit structural homologies with naturally occurring ligands and hence "share" cell surface receptors with these endogenous peptides. Our initial RIA demonstrate that antisera directed against the receptor-binding determinants of SP (-Phe-PheGly-Leu-Met-NH2) also recognize similar epitopes on the MV (Fig. 1) . When MV and SP are specifically cross-linked to "S-biosynthetically labeled cells, RabaSP immunoprecipitates the same protein from either MV or SP cross-linked preparations (Fig. 2) . Parallel studies conducted in a FACS, demonstrated that MV-FITC bound to cells could be specifically displaced by either unlabeled MV or unlabeled SP (Fig. 3) . Moreover, reciprocal experiments showed that specifically bound '251-SP could also be displaced by MV. Thus the immunoprecipitation and FACS results suggest that both MV and SP are binding to the SPR previously identified by '251-SP cross-linking studies (12) . The functional consequences of the above structural interactions were defined by examining the effects of RabaSP on MV plaque formation (Table I) , and SP on MV fusion (Fig. 4) . Moreover, given the extensive homologies observed in the family of G-protein coupled receptors, it is also possible that MV and other closely associated viruses may recognize a common structural motif on these receptors, and use more than one type of receptor in this family during fusion with specific cells. It should be noted that the contractile responses of guinea pig airways to SP were enhanced by infection with another paramyxovirus (parainfluenza-3) suggesting that a closely related virus may also interact and modulate the activities of the SPR (21) .
